Company / CapEx per Share
Merck & Co. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$1.61
FY2025
5-year range
$1.33 / $1.73
FY2021-FY2025
Trend
+21.7%
vs FY2024
Sector context
#9 of 192
Health Care
What the data says
Among 192 Health Care companies, Merck & Co. is in the top 5% for capex per share. CapEx per Share returned to growth in FY2025 after 2 years of decline, reaching $1.61.
Based on SEC 10-K filings.
1.61 in FY2025 with a 5-year CAGR of -0.5%. Top quartile in the Health Care sector.
Improved from $1.52 to $1.61 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -2.2%
- 5-Year CAGR
- -0.5%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 192This company $1.61 Sector average $3.54
▼
-54.4% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 21.7% year-over-year.
- Ranks #9 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2022.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.61 | +21.7% |
| FY2024 | $1.33 | -12.8% |
| FY2023 | $1.52 | -11.9% |
| FY2022 | $1.73 | +0.2% |
| FY2021 | $1.72 | +4.3% |
| FY2020 | $1.65 | +34.8% |
| FY2019 | $1.23 | +30.7% |
| FY2018 | $0.94 | +41.2% |
| FY2017 | $0.66 | +20.6% |
| FY2016 | $0.55 | +28.7% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026